SCHEMBL29352386

SCHEMBL29352386

CNc1ccc(Oc2ccc(-c3ccc(F)cc3)cc2)nc1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ SCN9A Q15858 3/20 0.41
▸ MEN1 O00255 4/20 0.39
▸ KMT2A Q03164 4/20 0.39
▸ KDM4E B2RXH2 2/20 0.39
▸ EGLN1 Q9GZT9 1/20 0.38
▸ F2 P00734 1/20 0.38
▸ F10 P00742 1/20 0.38
▸ PRSS1 P07477 1/20 0.38
▸ PRSS2 P07478 1/20 0.38
▸ PRSS3 P35030 1/20 0.38
▸ ST14 Q9Y5Y6 1/20 0.38
▸ MAPK14 Q16539 2/20 0.38
▸ SCN4A P35499 3/20 0.37
▸ L3MBTL1 Q9Y468 2/20 0.37
▸ HTT P42858 1/20 0.37
▸ ALDH1A1 P00352 3/20 0.36
▸ POLB P06746 1/20 0.36
▸ ATM Q13315 1/20 0.36
▸ HSPB1 P04792 1/20 0.35
▸ HTR2A P28223 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL22529941 1.00 SCN9A (0.41) SCN9AMEN1KMT2AKDM4EEGLN1
SCHEMBL22529924 0.86 AURKA (0.38) SCN9AMEN1KMT2AKDM4EEGLN1
SCHEMBL29352030 0.86 AURKA (0.38) SCN9AMEN1KMT2AKDM4EEGLN1
SCHEMBL21572280 0.82 MEN1 (0.44) SCN9AMEN1KMT2AKDM4EEGLN1
SCHEMBL22529903 0.79 MEN1 (0.47) SCN9AMEN1KMT2AKDM4EEGLN1
SCHEMBL29351760 0.79 MEN1 (0.47) SCN9AMEN1KMT2AKDM4EEGLN1
SCHEMBL22529968 0.77 TTK (0.32) MEN1KMT2A
SCHEMBL22529973 0.76 ADRB2 (0.45) SCN9AMAPK14SLC6A4
SCHEMBL22530411 0.75 ALDH1A1 (0.55) SCN9AKDM4EALDH1A1
SCHEMBL22529970 0.74 MEN1 (0.43) SCN9AMEN1KMT2AKDM4EMAPK14

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118994001-A NOTCH signaling pathway inhibitors and their use in cancer treatment 塞莱斯蒂亚生物技术股份公司 2024-11-22 — — CN disclosed
CN-113966324-B NOTCH signaling pathway inhibitors and their use in cancer treatment 塞莱斯蒂亚生物技术股份公司 2024-09-03 — — CN disclosed
CN-117794536-A Compounds for use in methods of treating autoimmune and inflammatory diseases 塞莱斯蒂亚生物技术股份公司 2024-03-29 — — CN disclosed
EP-3953335-A1 INHIBITORS OF NOTCH SIGNALLING PATHWAY AND USE THEREOF IN TREATMENT OF CANCERS Cellestia Biotech AG (CH) 2022-02-16 — — EP disclosed
CN-113966324-A NOTCH signaling pathway inhibitors and their use in cancer treatment 塞莱斯蒂亚生物技术股份公司 2022-01-21 — — CN disclosed
Send feedback